Protective oral vaccination against Infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Taghavian, Omid ^a   Spiegel, Holger ^a   Hauck, Rüdiger ^b   Hafez, Hafez M ^b   Fischer, Rainer ^a,c   Schillberg, Stefan ^a,d  

^a FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFECTIOUS BURSAL DISEASE VACCINE; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHICKEN; CONTROLLED STUDY; GROWTH RATE; INFECTIOUS BURSAL DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PROTECTION; VACCINATION; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS PARTICLE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; BURSA OF FABRICIUS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INFECTIOUS BURSAL DISEASE VIRUS; INJECTIONS, INTRAMUSCULAR; PICHIA; POULTRY DISEASES; VACCINATION; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 84893425641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083210     Document Type: Article

References (42)

1. Muller H, Mundt E, Eterradossi N, Islam MR (2012) Current status of vaccines against infectious bursal disease. Avian Pathol 41: 133-9.
2. Muller H, Islam MR, Raue R (2003) Research on infectious bursal disease-the past, the present and the future. Vet Microbiol 97: 153-65. (Pubitemid 37456672)
3. Lukert PD, Saif YM (1997) Infectious bursal disease. In: Calnek BW, editor. Disease of poultry. 10th ed. Ames: Iowa State Univ Press. pp. 721-38.
4. Sharma JM, Kim IJ, Rautenschlein S, Yeh HY (2000) Infectious bursal disease virus of chickens: pathogenesis and immunosuppression. Dev Comp Immunol 24: 223-35. (Pubitemid 30136302)
5. Delgui L, Ona A, Gutierrez S, Luque D, Navarro A, et al. (2009) The capsid protein of infectious bursal disease virus contains a functional alpha 4 beta 1 integrin ligand motif. Virology 386: 360-72.
6. Vasconcelos AC, Lam KM (1994) Apoptosis induced by infectious bursal disease virus. J Gen Virol 75: 1803-6. (Pubitemid 24211268)
7. Wyeth PJ, Cullen GA (1976) Maternally derived antibody-effect on susceptibility of chicks to infectious bursal disease. Avian Pathol 5: 253-60.
8. Macreadie IG, Vaughan PR, Chapman AJ, McKern NM, Jagadish MN, et al. (1990) Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine 8: 549-52.
9. Mahgoub HA (2012) An overview of infectious bursal disease. Arch Virol 157: 2047-2057.
10. Jackwood DH, Saif YM (1987) Antigenic diversity of infectious bursal disease viruses. Avian Dis 31: 766-770.
11. Synder DB (1990) Changes in the field status of infectious bursal disease virus. Avian Pathol 19: 419-23.
12. Rong J, Cheng T, Liu X, Jiang T, Gu H, et al. (2005) Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 23: 4844-4851. (Pubitemid 41242878)
13. Rautenschlein S, Kraemer C, Vanmarcke J, Montiel E (2005) Protective efficacy of intermediate and intermediate plus infectious bursal disease virus (IBDV) vaccines against very virulent IBDV in commercial broilers. Avian Dis 49: 231-237. (Pubitemid 40728410)
14. Kumar K, Singh KC, Prasad CB (2000) Immune responses to intermediate strain IBD vaccine at different levels of maternal antibody in broiler chickens. Trop Anim Health Prod 32: 357-360.
15. Berg TP (2000) Acute infectious bursal disease in poultry: a review. Avian Pathol 29: 175-194.
16. Wu J, Yu L, Li L, Hu J, Zhou J, et al. (2007) Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 5: 570-578. (Pubitemid 47196367)
17. Block H, Meyer-Block K, Rebeski DE, Scharr H, de Wit S, et al. (2007) A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies. Avian Pathol 36: 401-409. (Pubitemid 47509239)
18. Lombardo E, Maraver A, Espinosa I, Fernandez-Arias A, Rodriguez JF (2000) VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277: 345-357.
19. Birghan C, Mundt E, Gorbalenya AE (2000) A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J 19: 114-123. (Pubitemid 30009231)
20. Lejal N, Da Costa B, Huet JC, Delmas B (2000) Role of Ser-652 and Lys-692 in the protease activity of infectious bursal disease virus VP4 and identification of its substrate cleavage sites. J Gen Virol 81: 983-992. (Pubitemid 30189637)
21. Fahey KJ, Erny K, Crooks J (1989) A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70 (Pt6): 1473-1481. (Pubitemid 19165608)
22. Brandt M, Yao K, Liu M, Heckert RA, Vakharia VN (2001) Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus. J Virol 75: 11974-11982. (Pubitemid 33115869)
23. Azad AA, McKern NM, Macreadie IG, Failla P, Heine HG, et al. (1991) Physicochemical and immunological characterization of recombinant hostprotective antigen (VP2) of infectious bursal disease virus. Vaccine 9: 715-722.
24. Rong J, Jiang T, Cheng T, Shen M, Du Y, et al. (2007) Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens. Vaccine 25: 7900-7908. (Pubitemid 47632982)
25. Pitcovski J, Gutter B, Gallili G, Goldway M, Perelman B, et al. (2003) Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 21: 4736-4743. (Pubitemid 37329870)
26. Martinez-Torrecuadrada JL, Saubi N, Pages-Mante A, Caston JR, Espuna E, et al. (2003) Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine 21: 3342-3350. (Pubitemid 36700433)
27. Lee MS, Doong SR, Lai SY, Ho JY, Wang MY (2006) Processing of infectious bursal disease virus (IBDV) polyprotein and self-assembly of IBDV-like particles in Hi-5 cells. Biotechnol Prog 22: 763-769.
28. Lai SY, Lee MS, Chen HC, Shen PC, Jinn TR, et al. (2004) Production and purification of immunogenic virus-like particles formed by the chimeric infectious bursal disease virus structural protein, rVP2H, in insect larvae. Process Biochem 39: 571-577.
29. Wu H, Singh NK, Locy RD, Scissum-Gunn K, Giambrone JJ (2004) Immunization of chickens with VP2 protein of infectious bursal disease virus expressed in Arabidopsis thaliana. Avian Dis 48: 663-668. (Pubitemid 40234394)
30. Taghavian O, Mandal MK, Steinmetz NF, Rasche S, Spiegel H, et al. (2012) A potential nanobiotechnology platform based on infectious bursal disease subviral particles. RSC Adv 2: 1970-1978.
31. Shamsara M, Ghorashi SA, Ahmadian G (2006) Cloning and nucleotide analysis of the vp2 gene of a very virulent infectious bursal disease virus isolate from Iran. Acta Virol 50: 229-234. (Pubitemid 46032384)
32. Zhang X, Zhang X, Yang Q (2007) Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine. Vaccine 25: 3254-3262. (Pubitemid 46528000)
33. Wu S, Letchworth GJ (2004) High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol. Biotechniques 36: 152-154. (Pubitemid 38076393)
34. Li J, Liang X, Huang Y, Meng S, Xie R, et al. (2004) Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by codelivery with plasmid encoding chicken interleukin 2. Virology 329: 89-100. (Pubitemid 39346031)
35. Caston JR, Martinez-Torrecuadrada JL, Maraver A, Lombardo E, Rodriguez JF, et al. (2001) C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol 75: 10815-10828. (Pubitemid 33031551)
36. Coulibaly F, Chevalier C, Gutsche I, Pous J, Navaza J, et al. (2005) The birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120: 761-772. (Pubitemid 40568795)
37. Carballeda JM, Zoth SC, Gomez E, Gravisaco MJ, Berinstein A (2011) Activation of the immune response against Infectious Bursal Disease Virus after intramuscular inoculation of an intermediate strain. Immunobiology 216: 1028-1033.
38. Arnold M, Durairaj V, Mundt E, Schulze K, Breunig KD, et al. (2012) Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PLoS One 7: e42870.
39. Meeusen EN, Walker J, Peters A, Pastoret PP, Jungersen G (2007) Current status of veterinary vaccines. Clin Microbiol Rev 20: 489-510. (Pubitemid 47175016)
40. Shaw I, Davison TF (2000) Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine 18: 3230-3241. (Pubitemid 30408199)
41. Ismail NM, Saif YM (1991) Immunogenicity of infectious bursal disease viruses in chickens. Avian Dis 35: 460-469.
42. Jackwood DJ, Sommer SE, Knoblich HV (2001) Amino acid comparison of infectious bursal disease viruses placed in the same or different molecular groups by RT/PCR-RFLP. Avian Dis 45: 330-339. (Pubitemid 32540768)